Aarti Drugs Q2 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
332.65
-9.00 (-2.63%)
-9.00 (-2.63%)Volume18.54 K
Updated: Mon 17 Mar, 2025 | 15:55:36
NSE
333.20-7.00 (-2.06%)
-7.00 (-2.06%)Volume1.45 L
Updated: Mon 17 Mar, 2025 | 15:40:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Aarti Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 598.33 | 555.34 | 7.74% | 641.54 | -6.74% |
| Selling/ General/ Admin Expenses Total | 26.56 | 26.43 | 0.49% | 25.45 | 4.36% |
| Depreciation/ Amortization | 13.72 | 13.38 | 2.54% | 12.61 | 8.80% |
| Other Operating Expenses Total | 110.73 | 104.13 | 6.34% | 110.62 | 0.10% |
| Total Operating Expense | 545.01 | 503.76 | 8.19% | 577.71 | -5.66% |
| Operating Income | 53.32 | 51.58 | 3.37% | 63.83 | -16.47% |
| Net Income Before Taxes | 45.88 | 43.98 | 4.32% | 56.27 | -18.46% |
| Net Income | 35.01 | 33.24 | 5.31% | 39.60 | -11.59% |
| Diluted Normalized EPS | 3.83 | 3.62 | 5.80% | 4.29 | -10.72% |